CONMED Corp. buy Needham & Company LLC
Start price
24.07.23
/
50%
€109.00
Target price
24.07.24
€125.34
Performance (%)
-38.07%
End price
25.07.24
€67.50
Summary
This prediction ended on 25.07.24 with a price of €67.50. Massive losses of -38.07% were the result for the BUY prediction by Needham___Company_LL. Dividends of €0.74 are taken into consideration when calculating the performance. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| CONMED Corp. | 16.062% | 16.062% | -0.444% | -56.078% |
| iShares Core DAX® | 3,26 % | 2,07 % | 10,10 % | 63,73 % |
| iShares Nasdaq 100 | 5,70 % | -0,60 % | 28,97 % | 87,66 % |
| iShares Nikkei 225® | 7,77 % | -4,75 % | 52,09 % | 76,55 % |
| iShares S&P 500 | 2,80 % | 2,25 % | 23,75 % | 70,23 % |
Comments by Needham___Company_LL for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $139.00 price target on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten